Beth Israel Deaconess Medical Center KS121 — Brookline, Massachusetts

Beth Israel Deaconess Medical Center KS121 is a clinical research site located in Brookline, Massachusetts, United States 02215.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Center KS121 has participated in 1 clinical trials.

Therapeutic areas: Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Center KS121?

Beth Israel Deaconess Medical Center KS121 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Center KS121 conducted?

Beth Israel Deaconess Medical Center KS121 has 1 clinical trials on record. Their work covers Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).

Is Beth Israel Deaconess Medical Center KS121 accredited by Crixeo Health?

Beth Israel Deaconess Medical Center KS121 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Center KS121?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.